Afatinib is an inhibitor for EGFR and HER2, often used for treating NSCLC. It’s especially effective for those with certain genetic mutations like deletions in EGFR exon 19 or the L858R mutation in exon 21. It works by stopping EGFR signals.
You can get this drug in three doses: 20, 30, or 40 mg, all in a film-coated tablet. The go-to dose is 40 mg, taken once a day, ideally on an empty stomach. Each bottle holds 30 tablets.
